Cardiac Biomarkers Market 2020-2025: Research Report with Profitable Customization Analysis

As per the latest report by IMARC Group, titled “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global cardiac biomarkers market size reached US$ 7.5 Billion in 2019. Cardiac biomarkers refer to endogenous substances including enzymes, hormones and proteins, which are released into the bloodstream when the heart muscles are damaged, or the organ is stressed. Also known as cardiac enzymes, these substances include myoglobin, troponin, creatine kinase and ischemia-modified albumin. The measurement of these markers aids in diagnosing conditions associated with insufficient blood flow to the heart. They evaluate the heart’s function and assist in the early diagnosis of certain diseases. They are also used in the risk stratification of patients with chest pain and cardiovascular diseases (CVDs), such as suspected acute coronary syndrome (ACS) or myocardial infarction (MI). Physicians now widely prefer cardiac biomarker measurements over cardiac imaging diagnosis as these procedures are relatively simpler, cost-effective, and offer highly accurate results.

Request a Free Sample Research Report: https://www.imarcgroup.com/cardiac-biomarkers-market/requestsample

Changing lifestyles, hectic schedules and shifting dietary patterns have resulted in the frequent occurrence of chronic diseases such as diabetes and CVDs. This, along with growing awareness among the majority of the population regarding the importance of early diagnosis of these chronic diseases, is driving the demand for cardiac biomarkers. Also, quicker results and easy availability of point of care (POC) cardiac testing kits are further providing a thrust to the market growth. Furthermore, manufacturers are continually engaging in research and development (R&D) activities to develop technologically advanced product variants such as multi-assay biomarkers. Other factors creating a positive outlook for the market include rapid urbanization, rising disposable income, and favorable government initiative for making quality healthcare services accessible to all. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2020-2025.

Market Segmentation:
Breakup by Type
• Troponins (T and I)
• Myocardial Muscle Creatine Kinase (CK-MB)
• Myoglobin
• Brain Natriuretic Peptide (BNPs) or NT-proBNP
• Ischemia Modified Albumin (IMA)
• Others

Breakup by Location of Testing
• Laboratory Testing
• Point of Care Testing

Breakup by Application
• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others

Breakup by Region
• North America
• Asia Pacific
• Europe
• Middle East and Africa
• Latin America

Competitive Landscape
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key highlights of the report:
• Market Performance
• Market Outlook
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Competitive Structure
• Profiles of Key Players

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/cardiac-biomarkers-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Single User: https://www.imarcgroup.com/checkout?id=1178&method=1

Corporate User: https://www.imarcgroup.com/checkout?id=1178&method=3

Other Report:
https://www.syndicatedanalytics.com/isononanol-production-cost-analysis-report

https://www.syndicatedanalytics.com/lactic-acid-production-cost-analysis-report

https://www.syndicatedanalytics.com/hdpe-production-cost-analysis-report

https://www.syndicatedanalytics.com/ethylbenzene-production-cost-analysis-report

https://www.syndicatedanalytics.com/butanediol-production-cost-analysis-report

https://www.syndicatedanalytics.com/ethylene-glycol-production-cost-analysis-report

https://www.syndicatedanalytics.com/methacrylic-acid-production-cost-analysis-report

https://www.syndicatedanalytics.com/reformate-production-cost-analysis-report

https://www.syndicatedanalytics.com/syngas-production-cost-analysis-report

https://www.syndicatedanalytics.com/m-xylene-production-cost-analysis-report

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

This release was published on openPR.